Avalyn Pharma
The Senior Scientist, Formulation Development will lead the design and optimization of solution and dry powder inhaled formulations, aerosol performance, and drug‑device compatibility to support Avalyn's pulmonary fibrosis pipeline. This hands‑on laboratory role collaborates with cross‑functional teams to advance inhaled drug products through pre‑clinical, clinical, and commercial stages.
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company's approach focuses on delivering inhaled formulations of established medicines directly to lung tissue to potentially enhance efficacy and reduce systemic side effects. Its pipeline includes two clinical-stage programs, AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib), as well as a preclinical program, AP03, a fixed-dose combination of both agents.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Avalyn Pharma.
21% above the average for this role
Avalyn Pharma
Aug 5, 2025
Postdoctoral Research Associate
University of Sydney Union (USU)
Drug Product Formulation and Process Development Lead
Jobgether
Associate Director, Drug Product
Pulmovant
Formulation Scientist - Composition, Particle & Process Design
DSM SOFT PVT LTD
Formulation Scientist
Bristol Myers Squibb
Scientist I, Formulations
Flagship Pioneering, Inc.